Insider Shareholders with Direct Ownership of Schrodinger, Inc. (SDGR)
This section provides a comprehensive overview of the insiders with direct ownership of Schrodinger, Inc. (SDGR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Schrodinger, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Bill & Melinda Gates Foundation Trust
> 10% Shareholder |
10,981,664 | 4,000,000 | 6,981,664 $156 Million | 5 |
Nov 24, 2020
Reduced 22.27%
|
|
Richard Friesner
Director |
11,250 | 36,000 | 515,700 $11.5 Million | 5 |
Jun 18, 2024
Added 0.96%
|
|
Ramy Farid
President & CEO |
66,886 | 66,886 | 184,432 $4.11 Million | 2 |
Jan 04, 2023
Reduced 26.61%
|
|
Jorg Weiser
EVP & Managing Director |
37,623 | 87,787 | 117,052 $2.61 Million | 7 |
Apr 01, 2021
Reduced 0.36%
|
|
Kenneth Patrick Lorton
EVP, CTO & COO, Software |
29,382 | 27,401 | 42,061 $937,960 | 11 |
Mar 06, 2024
Added 11.7%
|
|
Shane Brauner
EVP & CIO |
24,776 | 23,319 | 24,867 $554,534 | 5 |
Dec 22, 2020
Reduced 7.44%
|
|
Jenny Herman
SVP & Controller |
19,858 | 3,004 | 19,074 $425,350 | 6 |
Mar 04, 2024
Added 27.71%
|
|
Margaret Dugan
Chief Medical Officer |
15,000 | 1,531 | 13,469 $300,358 | 2 |
Oct 15, 2024
Reduced 10.21%
|
|
Yvonne Tran
EVP, CLO & CPO |
94,344 | 122,512 | 11,963 $266,774 | 16 |
Feb 12, 2024
Reduced 5.96%
|
|
Michael Lynton
Director |
36,250 | 25,000 | 11,250 $250,875 | 8 |
Jun 18, 2024
Added 30.77%
|
|
Nancy Thornberry
Director |
31,050 | 19,800 | 11,250 $250,875 | 6 |
Jun 18, 2024
Added 30.77%
|
|
Gary Sender
Director |
40,025 | 28,775 | 11,250 $250,875 | 4 |
Jun 18, 2024
Added 30.77%
|
|
Rosana Kapeller Libermann
Director |
12,250 | 1,000 | 11,250 $250,875 | 4 |
Jun 18, 2024
Added 30.77%
|
|
Gary L Ginsberg
Director |
11,250 | 0 | 11,250 $250,875 | 2 |
Jun 18, 2024
Added 30.77%
|
|
Jeffrey Chodakewitz
Director |
11,250 | 0 | 11,250 $250,875 | 2 |
Jun 18, 2024
Added 30.77%
|
|
Arun Oberoi
Director |
11,250 | 0 | 11,250 $250,875 | 2 |
Jun 18, 2024
Added 30.77%
|
|
Robert Lorne Abel
Officer |
120,842 | 165,011 | 9,340 $208,282 | 16 |
Feb 12, 2024
Reduced 11.43%
|
|
Jennifer Daniel
EVP & Chief HR Officer |
77,084 | 100,996 | 6,688 $149,142 | 39 |
Apr 01, 2021
Reduced 5.88%
|
|
Geoffrey Craig Porges
EVP & CFO |
9,000 | 3,315 | 5,685 $126,775 | 2 |
Mar 04, 2024
Reduced 36.83%
|
|
Karen Akinsanya
President of R&D, Therapeutics |
70,623 | 70,623 | 0 $0 | 12 |
Oct 15, 2021
Reduced 100.0%
|
|
Joel Lebowitz
EVP & CFO |
79,261 | 79,261 | 0 $0 | 24 |
Sep 02, 2021
Reduced 100.0%
|
|
Charles Ardai
> 10% Shareholder |
0 | 13,377 | 0 $0 | 2 |
Nov 12, 2020
Reduced 100.0%
|
|
Cony D'Cruz
EVP & Chief Business Officer |
42,699 | 42,699 | 0 $0 | 26 |
Mar 23, 2021
Reduced 100.0%
|